LEWIS; Richard Thomas
Patent Applications and Registrations
Patent applications and USPTO patent grants for LEWIS; Richard Thomas.The latest application filed is for "gls1 inhibitors for treating disease".
Company Profile
3.23.24
- LEWIS; Richard Thomas - Missouri City TX
- Lewis; Richard Thomas - Auburn OH
- Lewis; Richard Thomas - Framingham MA
- Lewis; Richard Thomas - Bishops Stortford GB
- Lewis; Richard Thomas - Farmingham MA
- Lewis; Richard Thomas - Bishop's Stortford GB
- Lewis, Richard Thomas - Strongsville OH
- Lewis; Richard Thomas - Harlow GB
Patent Activity
| Patent | Date |
|---|---|
| Gls1 Inhibitors For Treating Disease App 20210122744 - LEWIS; Richard Thomas ; et al. | 2021-04-29 |
| GLS1 inhibitors for treating disease Grant 10,738,043 - Lewis , et al. A | 2020-08-11 |
| Heterocyclic Inhibitors Of Kdm5 For The Treatment Of Disease App 20190135793 - PETROCCHI; Alessia ; et al. | 2019-05-09 |
| Method of producing needle coke for low CTE graphite electrodes Grant 10,253,264 - Miller , et al. | 2019-04-09 |
| Gls1 Inhibitors For Treating Disease App 20190031651 - LEWIS; Richard Thomas ; et al. | 2019-01-31 |
| GLS1 inhibitors for treating disease Grant 10,125,128 - Lewis , et al. November 13, 2 | 2018-11-13 |
| Method Of Producing Needle Coke For Low Cte Graphite Electrodes App 20180023004 - Miller; Douglas J. ; et al. | 2018-01-25 |
| Method of producing needle coke for low CTE graphite electrodes Grant 9,777,221 - Miller , et al. October 3, 2 | 2017-10-03 |
| Gls1 Inhibitors For Treating Disease App 20170001996 - Lewis; Richard Thomas ; et al. | 2017-01-05 |
| Heteroaryl Compounds as PIKK Inhibitors App 20120190666 - Bode; Christiane ; et al. | 2012-07-26 |
| Inhibitors of GLYT1 transporters Grant 8,163,956 - Blackaby , et al. April 24, 2 | 2012-04-24 |
| Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia Grant 7,851,638 - Blackaby , et al. December 14, 2 | 2010-12-14 |
| Azetidine Derivatives as GlyT1 Inhibitors App 20100222317 - Blackaby; Wesley Peter ; et al. | 2010-09-02 |
| Cyclohexanesulfonyl Derivatives As Glyt1 Inhibitors To Treat Schizophrenia App 20100029726 - Blackaby; Wesley Peter ; et al. | 2010-02-04 |
| Piperidine and azetidine derivatives as GlyT1 inhibitors Grant 7,655,644 - Blackaby , et al. February 2, 2 | 2010-02-02 |
| Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia Grant 7,626,056 - Blackaby , et al. December 1, 2 | 2009-12-01 |
| Therapeutic Agents App 20090286765 - Blackaby; Wesley Peter ; et al. | 2009-11-19 |
| Process for making graphite articles Grant 7,544,316 - Kortovich , et al. June 9, 2 | 2009-06-09 |
| Piperidine And Azetidine Derivatives As Glyt1 Inhibitors App 20080090796 - Blackaby; Wesley Peter ; et al. | 2008-04-17 |
| Method Of Producing Needle Coke For Low CTE Graphite Electrodes App 20080003167 - Miller; Douglas J. ; et al. | 2008-01-03 |
| Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia App 20060276655 - Blackaby; Wesley Peter ; et al. | 2006-12-07 |
| Phenylpyridazine derivatives as ligands for gaba receptors App 20060235021 - Blackaby; Wesley ; et al. | 2006-10-19 |
| Process for making graphite articles App 20060192311 - Kortovich; James William ; et al. | 2006-08-31 |
| Imidazo-pyrimidine derivatives as ligands for GABA receptors Grant 7,030,128 - Blackaby , et al. April 18, 2 | 2006-04-18 |
| Imidazopyridines pyrimidines and triazines for enhancing cognition as gaba-a-alphas 5 receoptor subtype ligands App 20060040940 - Bettati; Michela ; et al. | 2006-02-23 |
| 5-phenyl[1,2,4]triazines as ligands for GABA-A .alpha.2/.alpha.3 receptors for treating anxiety or depression Grant 6,969,716 - Blackaby , et al. November 29, 2 | 2005-11-29 |
| Imidazo-triazine derivatives as ligands for GABA receptors Grant 6,936,608 - Bettati , et al. August 30, 2 | 2005-08-30 |
| Process of making graphite articles Grant 6,916,435 - Kortovich , et al. July 12, 2 | 2005-07-12 |
| Imidazo-pyrimidine derivatives as ligands for gaba receptors Grant 6,900,215 - Chambers , et al. May 31, 2 | 2005-05-31 |
| 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression App 20040192692 - Blackaby, Wesley Peter ; et al. | 2004-09-30 |
| Process of making graphite articles App 20040104497 - Kortovich, James William ; et al. | 2004-06-03 |
| Imidazo-pyrimidine derivatives as ligands for gaba receptors App 20040092533 - Blackaby, Wesley Peter ; et al. | 2004-05-13 |
| Pyrazino-pyridazine derivatives as ligands for GABA receptors Grant 6,730,676 - Blackaby , et al. May 4, 2 | 2004-05-04 |
| Imidazo-triazine derivatives as ligands for gaba receptors App 20040023964 - Bettati, Michela ; et al. | 2004-02-05 |
| 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors Grant 6,642,229 - Blackaby , et al. November 4, 2 | 2003-11-04 |
| 3-Phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors App 20030176449 - Blackaby, Wesley Peter ; et al. | 2003-09-18 |
| Triazolo-pyridazine derivatives as ligands for GABA receptors App 20030158203 - Carling, William Robert ; et al. | 2003-08-21 |
| Pyrazino-pyridazine derivatives as ligands for gaba receptors App 20030013716 - Blackaby, Wesley Peter ; et al. | 2003-01-16 |
| Triazolo-pyridazine derivatives as ligands for gaba receptors Grant 6,500,828 - Carling , et al. December 31, 2 | 2002-12-31 |
| Imidazo-pyrimidine derivatives as ligands for gaba receptors App 20020193385 - Chambers, Mark Stuart ; et al. | 2002-12-19 |
| Pin for connecting carbon electrodes and process therefor App 20010033036 - Shao, Richard Liichang ; et al. | 2001-10-25 |
| Process of making pins for connecting carbon electrodes Grant 6,280,663 - Shao , et al. August 28, 2 | 2001-08-28 |
| Tricyclic pyridone analogues as GABA-A receptor ligands Grant 6,133,255 - Harrison , et al. October 17, 2 | 2000-10-17 |
| Spiro-substituted azacyclic derivatives and their use as therapeutic agents Grant 5,811,431 - Ladduwahetty , et al. September 22, 1 | 1998-09-22 |
| Gem-disubstituted azacyclic tachykinin antagonists Grant 5,760,018 - Baker , et al. June 2, 1 | 1998-06-02 |
| Morpholine derivatives and their use as therapeutic agents Grant 5,719,149 - Finke , et al. February 17, 1 | 1998-02-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 